{
    "code": "02019444",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02019444",
    "time": "2015-08-23 10:34:52",
    "許可證字號": "衛署藥輸字第019444號",
    "註銷狀態": "已註銷",
    "註銷日期": "91\/12\/20",
    "註銷理由": "未依本署九十年五月二十三日公告事項一(二)執行",
    "有效日期": "91\/08\/25",
    "發證日期": "81\/08\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201944402",
    "中文品名": "待明必信靜脈凍晶注射劑１０公絲",
    "英文品名": "DOXORUBICIN MEIJI FOR I.V. INJECTION 10MG",
    "適應症": "急慢性白血球過多症、硬瘤、淋巴瘤、軟纖維性肉瘤、交感神經母細　　　　胞瘤、乳癌、肺癌。",
    "劑型": "243凍晶注射劑",
    "包裝": "小瓶",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "DOXORUBICIN HCL",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "0302201100  大明產業股份有限公司",
    "申請商地址": "台北市大同區長安西路一○六號四樓之三",
    "主製造廠": {
        "製造廠名稱": "F270011100  DONG-A PHARMACEUTICAL CO., LTD. (ANYANG FACTORY)",
        "製造廠廠址": "410 SUKSU-DONG ANYANG KYUNGGI-DO KOREA252,YONGDU-DONG,DONGDAEMUN-KU,SEOUL,KOREA",
        "製造廠公司地址": "252,YONGDU-DONG,DONGDAEMUN-KU,SEOUL,KOREA",
        "製造廠國別": "KOREA",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000610",
            "成分名稱": "DOXORUBICIN HCL",
            "含量描述": "10",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ]
}